Survivin-miRNA-loaded nanoparticles as auxiliary tools for radiation therapy: preparation, characterisation, drug release, cytotoxicity and therapeutic effect on colorectal cancer cells
- 20 March 2012
- journal article
- research article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 29 (7) , 685-694
Abstract
One of the main challenges in radiation oncology is to overcome the resistance of cancer cells against treatment by molecular targeted approaches. Among the most promising targets is the inhibitor of apoptosis protein survivin, known to be associated with increased tumour aggressiveness and therapy resistance. The objective of this study was the development of a human serum albumin-based nanoparticulate carrier system for plasmid-mediated RNA interference (miRNA) and the investigation of its in vitro efficacy on survivin knockdown and cellular toxicity in SW480 colorectal cancer cells. The results demonstrate a robust nanoparticulate system of a size around 220 nm with a plasmid incorporation efficacy of about 90%. Moreover, treatment of carcinoma cells with survivin-miRNA nanoparticles resulted in reduction of survivin expression by 50% and increased cytotoxicity if combined with ionising irradiation. These nanoparticles comprise a promising option to enhance the response of carcinoma cells to therapy with ionising irradiation.Keywords
This publication has 26 references indexed in Scilit:
- Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting2010
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticlesJournal of Controlled Release, 2008
- Survivin, cancer networks and pathway-directed drug discoveryNature Reviews Cancer, 2008
- The Role of Survivin for Radiation TherapyStrahlentherapie und Onkologie, 2007
- Preparation, characterization, cytotoxicity and transfection efficiency of poly(dl-lactide-co-glycolide) and poly(dl-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNAInternational Journal of Pharmaceutics, 2007
- Nanoparticles—a historical perspectiveInternational Journal of Pharmaceutics, 2007
- Molecular hurdles in polyfectin design and mechanistic background to polycation induced cytotoxicity☆Advanced Drug Delivery Reviews, 2006
- Albumin nanoparticles improved the stability, nuclear accumulation and anticytomegaloviral activity of a phosphodiester oligonucleotideJournal of Controlled Release, 2004
- Survivin as a Radioresistance Factor in Pancreatic CancerJapanese Journal of Cancer Research, 2000
- Poly(ethylenimine) and its role in gene deliveryJournal of Controlled Release, 1999